Urinary excretion of o-giucaric acid (uGA) is an index of type II hepatic microsomal enzyme induction, indirectly revealing possible organic effects of some drugs and environmental pollutants. However, its determination is often cumbersome. We suggest a new, fast microanalytical method for uGA determination in which J3-glucuronidase (BG; EC 3.2.1.31) activity inhibition produced by uGA-derived 1,4-o-glucarolactone is measured. With use of purified BG, the method is suitable for centrifugal analyzers, allowing assay of >100 samples per day. Moreover, the method measures uGA more accurately than other enzymatic methods based on BG inhibition. The within-day CV ranges from 7.9% to 4.6% (uGA 31.55-121.31 &molIL); the between-day CV ranges from 11.5% to 5.0% ( Different xenobiotic substances, including environmental pollutants and drugs, can activate the drug-metabolizing system in liver microsomes and are metabolized mainly by the cytochrome P-450 system of mono-oxygenases and other enzymes of the smooth endoplasmic reticulum (1).
1) in vitro determination of specific enzyme content and activity in liver biopsy specimens (4-6);
2) in vivo antipyrine or theophylline clearance, indicators of phase-I reactions (7, 8) ;
3) serum y-glutamyltransferase (EC 2.3.2.2) determination (9-11); 4) urinary excretion of 63-hydroxycortisol, indicator of phase-I reactions (8, 12, 13); and 5) urinary excretion of D-glucaric (or ri-saccharic) acid (uGA), indicator of phase-il reactions (14-18).
Demonstrably (2,3, 14-18), uGA is a suitable indicator of liver microsomal enzyme induction, thus giving indirect information on the presence of foreign toxic substances (12, 19, 20) , although a recent paper (21) questions this assumption and suggests that uGA is a less-sensitive index than antipyrine clearance, at least for low dosesof phenobarbital.
uGA can be quantified either by chromatography (22-24), which is complex and not particularly favored in a clinical laboratory, or by enzymatic methods (25-31).
These rely on two different principles: 1) uGA in urine is in equilibrium with 1,4-and 1,6-glucarolactone (GL). Boiling urine at an acidic pH transforms uGA into 1,4-GL. uGA can be indirectly measured by means of the competitive inhibition that 1,4-GL exerts on the enzymatic activity of /3-glucuronidases (BC 3.2.1.31) (BGs) on adequate substrates, such as phenolphthalein-3-nglucuronide and 4-nitrophenyl-/3-n-glucuronide (NP-G) (25) (26) (27) (28) (29) (30) .
2) Treatment of uGA with a bacterial extract containing glucarate dehydratase (EC 4.2.1.40) and ketodeoxyglucarate aldolase (EC 4.1.2.20) leads to quantitative formation of pyruvate, which is then assayed by use of lactate dehydrogenase (EC 1.1.1.27) (31). Table 1 lists advantages and disadvantages of both groups of methods.
For sample throughput to be high, tests based on enzymatic inhibition (26) (27) (28) (29) (30) are usually preferred. Here we report a new method for uGA assay, which is faster, yielding about 100 uGA determinations per day, but is as precise and accurate as previous procedures.
For reasons of economy we also propose a method to produce, through simple chromatographic purification of BG, an enzyme suitable for uGA determination that will be sufficiently sensitive to inhibition by 1,4-GL--although the method also works with a commercially available BG.
MaterIals and Methods

Specimen Collection and Preparation
Specimens of first morning urine from apparently healthy people were stored at room temperature if analyzed the Rsf. no.
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BG Purification
Treatment of Standards and Urine Samples for uGA Determination
Adjust the pH to between 4.0 and 6.0 by adding glacial acetic acid to those centrifuged urine specimens whose pH Programming for the Cobas Bio and Fara is shown in Table 2 .
Assay of Creatinine (GRE)
CRE was determined with the "Creatinine Merckotest A" (see Reagents). Specimens from children younger than 6 y were first boiled for 4 hat pH 2.0, in capped tubes, to convert creatine to creatinine. The initial volume was restored by adding distilled water. 
Interference:
An aliquot of the interferent substance to be tested was added (1/10 by vol) to a urine pool to obtain the following final concentrations: hemoglobin 5 g/L, biirubin 80 mgfL, porphyrins 2 mg/L, ascorbic acid 2 g/L, glucose 100 gfL, and albumin up to 18 gIL. Each of these samples and a control aliquot, to which distilled water (1/10 by vol) was added, were assayed in triplicate.
Method comparison: uGA concentration was measured by both the present method and that of Simmons et al. (26) in urine samples from 152 people (including 21 apparently healthy people, 27 pregnant women, six drug addicts, 27 patients who were undergoing benzodiazepine treatment, and 71 patients on anti-epileptic medication). All samples were assayed in duplicate by each method, and data were subjected to regression analysis.
Reference Interval
We selected 183 males and 186 females (one to 65 y old) and categorized them by age, according to IFCC recommendations (33). All were apparently healthy people who were undergoing routine analyses at the Hospital of Desio, Milano, Italy. They had no smoking and (or) alcohol abuse habits and did not present any history of medication or drug consumption in the 30 days before specimen collection. The results of their uGA assay were evaluated according to IFCC recommendations (34).
Results
Choice of the Source of BG
As a first step to achieve good quality, we studied the Km for NP-G and the K1 for GL of commercially available BGs (Table 3) . BG from Helix pomatia (Boehringer) was used both as supplied and after our purification through affinity chromatography. The enzyme preparation obtained by affinity chromatography performed as well as the preparations (from the same source) that we purified by sequential purification through gel permeation chromatography, ionexchange chromatography, and affinity chromatography on Con-A.
For good sensitivity to GL inhibitor, the K, for 1,4-GL obtained by boiling GA solutions at pH 2.0, as well as the Km for NP-G for a high catalytic velocity, should be as low as possible. The Km and K, reported in Table 3 show that the best results are to be expected with BG from Helix pomatia, purified either by affinity chromatographyin our laboratory or by gel permeation chromatography as is done by Sigma.
Use of Boehringer's BG purified by affinity chromatography offers advantages, both in terms of much higher specific activity and lower cost.
Bovine-liver
BG performs much less satisfactorily with NP-G than with phenolphthalein-/3-glucuronide as substrate.
Sample Preparation
Transformation of uGA into 1,4-GL is maximal when urine is boiled at a pH <2.5 (data not shown). The specimens must be diluted by 1.5 mol/L HC1 or 1.5 molIL KOH as little as possible, if one is to obtain good precision at the upper limit of the reference interval.
Reaction Conditions
It is important that the reaction conditions for uGA determination are set to have the greatest difference between the reaction rates of BG in acid-boiled or alkalineboiled urines. This was the case under the following reaction conditions (data not shown): NP-G 1 mmol/L, acetate buffer 0.8 mol/L, pH 5.0-the same conditions used by Jung et al. (27) .
Validation of the Method
Calibration curve: Plotting inhibition results according to Dixon (35) gives a linear calibration curve. Linear regression analysis of data from 30 sets of standards under different concentrations (Figure 1) confirms the linearity for uGA concentrations from 10 to 200 jtmollL. This is equivalent to the range obtained by the method of Jung et al. (27) and slightly lower than that of the enzymatic method of Marsh (31).
Detection limit: The detection limit for the method is 6.0 janol/L, which is in agreement with that for most other methods (26-28, 31) .
Within-day precision: Data from 20 replicates of uGA determinations at three different concentrations are reported in Table 4 . The CV ranges from 4.6% to 7.9% at 121.31 and 31.55 1zmolfL, respectively.
Between-day precision:
Between-day precision at three different uGA concentrations was evaluated in triplicate. The data reported in Table 4 demonstrate that precision increases with increasing uGA concentrations.
Our CVs are higher than CVs reported by Jung et al. (27) The reference intervals, 2.5 and 97.5 fractiles, were calculated by parametric methodology (34) for females older than 14 y, females younger than 14 y, and for males. The fractiles and their 90% confidence intervals are reported in Table 6 .
Discussion
This methodfor measurementof uGA excretionis quicker and much simpler than the proceduresfor uGA determination proposed so far (22-28, 31) , while providing similar linearity, precision, accuracy, and analytical sensitivity (25) (26) (27) (28) (29) (30) (31) . Our method allows many tests (80-100/day) to be performedroutinely; hitherto, the maximum rate was 40-60 determinations per day (26) (27) .
To achieve these features we perform the enzymatic determination of uGA with use of a purified BG, whose reaction on the substrate NP-G can be easily monitored at pH 5.0 (the pH of the reaction solution), especially in a centrifugal analyzer.
This fact makes unnecessary the usual stopping of the NP-G enzymatic hydrolysis by adding NaOH (26,27) to the reaction solution to increase its pH to alkaline values before reading. In fact, at pH 5.0 the NP-G hydrolysis by BG produces an absorbance increase linearly related to the concentration of the 4-nitrophenol released and measurable between 400 and 405 mu (the nonspecific absorbance of urine is too high below 400 nm). Under these conditions and in the absence of inhibitors, NP-G enzymatic hydrolysis produces a typical absorbance increase of -0.20 A at 401 nnL BGs from bovine liver and from Helix pomatia as crude extracts need to be purified, because they are not suitable to measure uGA under the conditions described. Purification of BG from Helix pomatia (Boehringer) is very simple in comparison with the purification specified in some methods, 
Reference Interval
Results of uGA determinations on subjects of the population described above, submitted to the Kolmogorov-Smirnovtest (34) for normality of the frequency distribution, did not showany deviation from normality for either sex. Data referring to age groups of apparently healthy people, categorized by sex, are reported in Figure 3 .
In children younger than 14 y, uGA excretion (expressed in pmol per gram of CRE) does not differ in males (81 subjects, mean value 13.77) and females (84 subjects, mean value 14.59). Values for uGA excretion did not change (Table 6 ) in the group of 102 men older than 14 y (14.39), whereas higher (P <0.001) values were observed for women older than 14 y (102 subjects, mean value 18.70). The latter also have higher interindividual variability than men, as also reported by March et al. (37) . namely those for BG from rat liver (25, 27) Steinberg et al. (29) , who reported uGA excretion in mmol per mole of CRE, found a wider reference interval for children younger than 15 y than for adults. We did not find such a difference when we treated the children's urine samples to transform the excreted creatine into creatinine (seeMethods); in fact, low values for creatinine in urine from children younger than 6 y, because of incomplete transformation of creatine to creatinine, give rise, by calculation, to apparently high results for uGA excretion.
In conclusion, the procedure described here for enzymatic measurement of uGA excretion is characterized by good sensitivity, precision comparable with that reported for other methods (28, 31) , good specificity, accuracy excelling that for existing methods (26, 28) , and faster analysis. 17, 18 ). These differences can probably be explained with the hypothesis that "these tests probably reflect the activity of different but overlapping parts of the nuicrosomal enzyme system" (8). This same author (8) stresses the potentially useful application of uGA determination for studies of microsomal enzyme function in occupational medicine. A more substantiated decision on the use of these tests can be made when a much larger number of people is studied as compared with the small groups investigated hitherto. Considering this important goal, the usefulness of our method is confirmed by the ease with which it permits, for health control or epidemiological studies, the follow-up of large populations of special subjects such as pregnant women, drug addicts, and people exposed to environmental toxic substances.
